172 related articles for article (PubMed ID: 6546922)
1. Glucagon-related peptides in the human gastrointestinal mucosa.
Baldissera FG; Holst JJ
Diabetologia; 1984 Mar; 26(3):223-8. PubMed ID: 6546922
[TBL] [Abstract][Full Text] [Related]
2. Distribution of oxyntomodulin and glucagon in the gastrointestinal tract and the plasma of the rat.
Kervran A; Blache P; Bataille D
Endocrinology; 1987 Aug; 121(2):704-13. PubMed ID: 3595539
[TBL] [Abstract][Full Text] [Related]
3. Development of an oxyntomodulin/glicentin C-terminal radioimmunoassay using a "thiol-maleoyl" coupling method for preparing the immunogen.
Blache P; Kervran A; Martinez J; Bataille D
Anal Biochem; 1988 Aug; 173(1):151-9. PubMed ID: 3189794
[TBL] [Abstract][Full Text] [Related]
4. Gut glucagon, enteroglucagon, gut glucagonlike immunoreactivity, glicentin--current status.
Holst JJ
Gastroenterology; 1983 Jun; 84(6):1602-13. PubMed ID: 6188645
[TBL] [Abstract][Full Text] [Related]
5. Oxyntomodulin and glicentin: brain-gut peptides in the rat.
Blache P; Kervran A; Bataille D
Endocrinology; 1988 Dec; 123(6):2782-7. PubMed ID: 3197645
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic and intestinal processing of proglucagon in man.
Orskov C; Holst JJ; Poulsen SS; Kirkegaard P
Diabetologia; 1987 Nov; 30(11):874-81. PubMed ID: 3446554
[TBL] [Abstract][Full Text] [Related]
7. Glicentin and gastric inhibitory polypeptide immunoreactivity in endocrine cells of the gut and pancreas.
Larsson LI; Moody AJ
J Histochem Cytochem; 1980 Sep; 28(9):925-33. PubMed ID: 6997368
[TBL] [Abstract][Full Text] [Related]
8. Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin.
Holst JJ
Biochem J; 1982 Dec; 207(3):381-8. PubMed ID: 7165698
[TBL] [Abstract][Full Text] [Related]
9. Distribution of glucagon-like peptide I in canine and feline pancreas and gastrointestinal tract.
Vaillant CR; Lund PK
J Histochem Cytochem; 1986 Sep; 34(9):1117-21. PubMed ID: 3755450
[TBL] [Abstract][Full Text] [Related]
10. Extraction, gel filtration pattern, and receptor binding of porcine gastrointestinal glucagon-like immunoreactivity.
Holst JJ
Diabetologia; 1977 Apr; 13(2):159-69. PubMed ID: 856653
[TBL] [Abstract][Full Text] [Related]
11. Naturally occurring products of proglucagon 111-160 in the porcine and human small intestine.
Buhl T; Thim L; Kofod H; Orskov C; Harling H; Holst JJ
J Biol Chem; 1988 Jun; 263(18):8621-4. PubMed ID: 3379036
[TBL] [Abstract][Full Text] [Related]
12. Glicentin immunoreactive cells: their relationship to glucagon-producing cells.
Ravazzola M; Siperstein A; Moody AJ; Sundby F; Jacobsen H; Orci L
Endocrinology; 1979 Aug; 105(2):499-508. PubMed ID: 378654
[TBL] [Abstract][Full Text] [Related]
13. The biological significance of "enteroglucagon." Present status.
Bataille D; Jarrousse C; Kervran A; Depigny C; Dubrasquet M
Peptides; 1986; 7 Suppl 1():37-42. PubMed ID: 3529053
[TBL] [Abstract][Full Text] [Related]
14. [Glucagon-like-immunoreactivity and enteroglucagon, with special reference to immunohistochemical observation].
Tsutsumi Y; Watanabe K
Nihon Rinsho; 1982; 40(5):1052-64. PubMed ID: 6750177
[No Abstract] [Full Text] [Related]
15. Glucagon-37 (oxyntomodulin) and glucagon-29 (pancreatic glucagon) in human bowel: analysis by HPLC and radioreceptorassay.
Munck A; Kervran A; Marie JC; Bataille D; Rosselin G
Peptides; 1984; 5(3):553-61. PubMed ID: 6473171
[TBL] [Abstract][Full Text] [Related]
16. Molecular forms of glucagon-like immunoreactivity in porcine intestine and pancreas.
Ghatei MA; Uttenthal LO; Bryant MG; Christofides ND; Moody AJ; Bloom SR
Endocrinology; 1983 Mar; 112(3):917-23. PubMed ID: 6822217
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical studies on glucagon, glicentin and pancreatic polypeptide in human stomach: normal and pathological conditions.
Tsutsumi Y
Histochem J; 1984 Aug; 16(8):869-83. PubMed ID: 6207142
[TBL] [Abstract][Full Text] [Related]
18. Chronic pancreatitis and diabetes mellitus: plasma and gastroduodenal mucosal profiles of regulatory peptides (gastrin, motilin, secretin, cholecystokinin, gastric inhibitory polypeptide, somatostatin, VIP, substance P, pancreatic polypeptide, glucagon, enteroglucagon, neurotensin).
Domschke S; Bloom SR; Adrian TE; Lux G; Domschke W
Hepatogastroenterology; 1988 Oct; 35(5):229-37. PubMed ID: 2465985
[TBL] [Abstract][Full Text] [Related]
19. [Bioactive "enteroglucagon" (oxyntomodulin): evidence for a C-terminal extension of the glucagon molecule].
Bataille D; Tatemoto K; Coudray AM; Rosselin G; Mutt V
C R Seances Acad Sci III; 1981 Oct; 293(6):323-8. PubMed ID: 6797684
[TBL] [Abstract][Full Text] [Related]
20. Glucagon- and PP-related peptides of intestinal L cells and pancreatic/gastric A or PP cells. Possible interrelationships of peptides and cells during evolution, fetal development and tumor growth.
Solcia E; Fiocca R; Capella C; Usellini L; Sessa F; Rindi G; Schwartz TW; Yanaihara N
Peptides; 1985; 6 Suppl 3():223-9. PubMed ID: 3841689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
